Literature DB >> 19307610

Leukocyte elastase induces lung epithelial apoptosis via a PAR-1-, NF-kappaB-, and p53-dependent pathway.

Tomoko Suzuki1, Cory Yamashita, Rachel L Zemans, Natalie Briones, Annemie Van Linden, Gregory P Downey.   

Abstract

Leukocyte elastase induces apoptosis of lung epithelial cells via alterations in mitochondrial permeability, but the signaling pathways regulating this response remain uncertain. Here we investigated the involvement of proteinase-activated receptor-1 (PAR-1), the transcription factor NF-kappaB, and the protooncogene p53 in this pathway. Elastase-induced apoptosis of lung epithelial cells correlated temporally with activation of NF-kappaB, phosphorylation, and nuclear translocation of p53, increased p53 up-regulated modulator of apoptosis (PUMA) expression, and mitochondrial translocation of Bax resulting in enhanced permeability. Elastase-induced apoptosis was also prevented by pharmacologic inhibitors of NF-kappaB and p53 and by short interfering RNA knockdown of PAR-1, p53, or PUMA. These inhibitors prevented elastase-induced PUMA expression, mitochondrial translocation of Bax, increased mitochondrial permeability, and attenuated apoptosis. NF-kappaB inhibitors also reduced p53 phosphorylation. We conclude that elastase-induced apoptosis of lung epithelial cells is mediated by a PAR-1-triggered pathway involving activation of NF-kappaB and p53, and a PUMA- and Bax-dependent increase in mitochondrial permeability leading to activation of distal caspases. Further, p53 contributes to elastase-induced apoptosis by both transcriptional and post-transcriptional mechanisms.

Mesh:

Substances:

Year:  2009        PMID: 19307610      PMCID: PMC2784410          DOI: 10.1165/rcmb.2008-0157OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  76 in total

1.  Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria.

Authors:  S G Kennedy; E S Kandel; T K Cross; N Hay
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1.

Authors:  Shashirekha Shetty; Bonnie A Graham; Jennifer G Brown; Xiaojie Hu; Nicolette Vegh-Yarema; Gary Harding; James T Paul; Spencer B Gibson
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 3.  Apoptosis in heart failure.

Authors:  H N Sabbah; V G Sharov
Journal:  Prog Cardiovasc Dis       Date:  1998 May-Jun       Impact factor: 8.194

Review 4.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

5.  Kinetics of pulmonary neutrophil recruitment and clearance in a natural and spontaneously resolving model of airway inflammation.

Authors:  T J Brazil; M P Dagleish; B C McGorum; P M Dixon; C Haslett; E R Chilvers
Journal:  Clin Exp Allergy       Date:  2005-07       Impact factor: 5.018

6.  Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS).

Authors:  G Matute-Bello; W C Liles; K P Steinberg; P A Kiener; S Mongovin; E Y Chi; M Jonas; T R Martin
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

7.  Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum.

Authors:  Z H Qin; R W Chen; Y Wang; M Nakai; D M Chuang; T N Chase
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

8.  Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max.

Authors:  H C Kirch; S Flaswinkel; H Rumpf; D Brockmann; H Esche
Journal:  Oncogene       Date:  1999-04-29       Impact factor: 9.867

9.  NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling.

Authors:  J A Romashkova; S S Makarov
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

10.  Neutrophil elastase and elastase-rich cystic fibrosis sputum degranulate human eosinophils in vitro.

Authors:  H Liu; S C Lazarus; G H Caughey; J V Fahy
Journal:  Am J Physiol       Date:  1999-01
View more
  33 in total

Review 1.  Contribution of neutrophils to acute lung injury.

Authors:  Jochen Grommes; Oliver Soehnlein
Journal:  Mol Med       Date:  2010-10-18       Impact factor: 6.354

Review 2.  Coagulation, protease-activated receptors, and viral myocarditis.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  J Cardiovasc Transl Res       Date:  2013-11-08       Impact factor: 4.132

3.  Roles of PAR1 and PAR2 in viral myocarditis.

Authors:  Nigel Mackman; Silvio Antoniak
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 4.  Roles of proteolysis in regulation of GPCR function.

Authors:  G S Cottrell
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

5.  The yin and yang of cystic fibrosis transmembrane conductance regulator function: implications for chronic lung disease.

Authors:  Neeraj Vij; Gregory P Downey
Journal:  Am J Respir Crit Care Med       Date:  2013-01-15       Impact factor: 21.405

6.  Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity.

Authors:  Silvio Antoniak; Kohei Tatsumi; Clare M Schmedes; Steven P Grover; Rafal Pawlinski; Nigel Mackman
Journal:  J Mol Cell Cardiol       Date:  2018-08-10       Impact factor: 5.000

7.  Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2).

Authors:  Rithwik Ramachandran; Koichiro Mihara; Hyunjae Chung; Bernard Renaux; Chang S Lau; Daniel A Muruve; Kathryn A DeFea; Michel Bouvier; Morley D Hollenberg
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

Review 8.  Neutrophil-Epithelial Interactions: A Double-Edged Sword.

Authors:  Charles A Parkos
Journal:  Am J Pathol       Date:  2016-04-12       Impact factor: 4.307

9.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

10.  Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cells.

Authors:  Lilibeth A Salvador; Kanchan Taori; Jason S Biggs; Jean Jakoncic; David A Ostrov; Valerie J Paul; Hendrik Luesch
Journal:  J Med Chem       Date:  2013-01-28       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.